Malin PLC is a publicly listed company investing in highly innovative life sciences companies, focusing on oncology, immunology, and genetic diseases with the aim of providing transformative treatments for patients.

Malin PLC

Onoff

Viewport Meta

IPhone / Mobile Compatible

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

WordPress

Global Site Tag

Font Awesome

Google Analytics 4

Project Manager

Chuck Cohoon

Project Accountant/Manager

David Langlois

General Manager

Alain Malin

Executive Director/Company Secretary

Fiona Dunlevy

Business Management

Liam Daniel

President

Malin Maitrejean

Partner

Sheila Malin

Kirsten Drejer

Rudy Mareel

Non Executive Director

Sean Murphy

Co-Founder

John Given

Chairman

Adrian Howd

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics.

3D4Medical is a technology company that specializes in the development of medical, health, and fitness apps for professional reference.

Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.

Novan is a clinical-stage drug development company developing deliverable nitric oxide.

Early Stage Venture Investors with Investments in West Coast (Top 10K)

Late Stage Venture Investors with Investments in East Coast

Late Stage Venture Investors with Investments in West Coast

Private Equity Firms with Investments in East Coast

Malin Corporation plc (“Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut and Research Triangle, North Carolina, USA.


Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.

Ireland Strategic Investment Fund

Venture Round - Malin Corporation

Dublin

Ireland

Europe

Malin Corporation

Malin Corporation CEO to step down by end of 2023

Malin Corporation invests in innovative life sciences companies focusing on oncology, immunology, and genetic diseases to develop transformative healthcare technologies.

India

Asia

United States

North America

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 1:34 PM	2cc68451
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 1:34 PM	6eb09820
crunchbase trigger	general	Nov 19, 2024 1:34 PM	461d78b1
crunchbase profile	general	Nov 20, 2024 11:06 AM	7d292c0a
li profile	general	Nov 19, 2024 1:34 PM	273bc38a
translate crunchbase fundingrounds	general	Nov 20, 2024 11:43 AM	af1d7c17
peers	general	Nov 19, 2024 1:34 PM	5150a946
news basic	general	Nov 19, 2024 1:34 PM	562eb151
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

MALI

COM:MALINPLC

Malin PLC